Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs MEDVidi
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict51/ 100
Grade C · #435MEDVidi
MEDVidi is a US telehealth platform whose licensed providers evaluate patients and prescribe GLP-1 weight-management medications, including brand-name Zepbound (tirzepatide) and Wegovy (semaglutide), plus…
Visit MEDVidiThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 51/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. MEDVidi still earns its place — people who want a licensed provider to prescribe brand glp-1 they fill with insurance.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results64
92
Real-world results64
97Price honesty20
97
Price honesty20
96Prescriber access55
96
Prescriber access55
88Formulary choice48
88
Formulary choice48
95Cancellation fairness56
95
Cancellation fairness56
93Member support70
93
Member support70
Price, coverage & features
| Metric | CoreAge Rx | MEDVidi |
|---|---|---|
| Verdict Score | 94/100 | 51/100 |
| Grade | A | C |
| Semaglutide | $149/mo | Not disclosed |
| Tirzepatide | $349/mo | Not disclosed |
| Coverage | All 50 states | Not disclosed |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
MEDVidi
What we like
- Licensed providers can prescribe brand-name Zepbound and Wegovy
- Transparent flat consultation fees (195 dollar initial, 159 dollar follow-up)
- Prescriptions sent to the patient's pharmacy of choice, so insurance can be used
The caveats
- Consult-fee model: medication is not included and its cost is separate
- No medication pricing is published
- State list is shown as a map rather than enumerated
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
People who want a licensed provider to prescribe brand glp-1 they fill with insurance.
Visit MEDVidi Read the full MEDVidi review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programmes closest to it, and the same shortlist for MEDVidi does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.